Annual Total Long Term Liabilities
$1.58 M
+$1.53 M+3475.96%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual total long term liabilities is $1.58 million, with the most recent change of +$1.53 million (+3475.96%) on December 31, 2023.
- During the last 3 years, XLO annual total long term liabilities has risen by +$1.40 million (+776.11%).
- XLO annual total long term liabilities is now at all-time high.
Performance
XLO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$15.66 M
-$2.15 M-12.09%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly total long term liabilities is $15.66 million, with the most recent change of -$2.15 million (-12.09%) on September 30, 2024.
- Over the past year, XLO quarterly long term liabilities has increased by +$7.52 million (+92.36%).
- XLO quarterly long term liabilities is now -93.59% below its all-time high of $244.31 million, reached on September 30, 2021.
Performance
XLO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
XLO Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +3476.0% | +92.4% |
3 y3 years | +776.1% | +92.4% |
5 y5 years | +100.0% | +92.4% |
XLO Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +3476.0% | -38.0% | +92.4% |
5 y | 5-year | at high | +3476.0% | -93.6% | +92.4% |
alltime | all time | at high | -100.0% | -93.6% | +92.4% |
Xilio Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $15.66 M(-12.1%) |
Jun 2024 | - | $17.82 M(-29.5%) |
Mar 2024 | - | $25.26 M(+210.3%) |
Dec 2023 | $1.58 M(+3476.0%) | $8.14 M(-3.2%) |
Sep 2023 | - | $8.41 M(-3.2%) |
Jun 2023 | - | $8.69 M(-17.4%) |
Mar 2023 | - | $10.52 M(-15.2%) |
Dec 2022 | $44.10 K | $12.40 M(-13.1%) |
Sep 2022 | - | $14.27 M(-11.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $16.14 M(-10.4%) |
Mar 2022 | - | $18.01 M(-9.3%) |
Dec 2021 | $68.00 K(-62.2%) | $19.85 M(-91.9%) |
Sep 2021 | - | $244.31 M(+1.8%) |
Jun 2021 | - | $240.03 M(+146.3%) |
Dec 2020 | $180.00 K(-21.8%) | $97.45 M |
Dec 2019 | $230.10 K(>+9900.0%) | - |
Dec 2018 | $0.00(0.0%) | - |
Dec 2017 | $0.00(0.0%) | - |
Dec 2016 | $0.00 | - |
FAQ
- What is Xilio Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Xilio Therapeutics?
- What is Xilio Therapeutics annual total long term liabilities year-on-year change?
- What is Xilio Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly long term liabilities year-on-year change?
What is Xilio Therapeutics annual total long term liabilities?
The current annual total long term liabilities of XLO is $1.58 M
What is the all time high annual total long term liabilities for Xilio Therapeutics?
Xilio Therapeutics all-time high annual total long term liabilities is $1.58 M
What is Xilio Therapeutics annual total long term liabilities year-on-year change?
Over the past year, XLO annual total long term liabilities has changed by +$1.53 M (+3475.96%)
What is Xilio Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of XLO is $15.66 M
What is the all time high quarterly long term liabilities for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly total long term liabilities is $244.31 M
What is Xilio Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, XLO quarterly total long term liabilities has changed by +$7.52 M (+92.36%)